Next Article in Journal
Copaifera langsdorffii Novel Putative Long Non-Coding RNAs: Interspecies Conservation Analysis in Adaptive Response to Different Biomes
Next Article in Special Issue
Biogenesis, Stabilization, and Transport of microRNAs in Kidney Health and Disease
Previous Article in Journal
MicroRNA-Attenuated Virus Vaccines
Previous Article in Special Issue
The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)
Open AccessReview

LncRNAs in TGF-β-Driven Tissue Fibrosis

by 1,2,†, 2,3,† and 2,*
Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, Lui Che Woo Institute of Innovative Medicine, Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong 999077, China
Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong 999077, China
Department of Nephrology, Tongji University School of Medicine, Shanghai 200065, China
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Non-Coding RNA 2018, 4(4), 26;
Received: 15 August 2018 / Revised: 22 September 2018 / Accepted: 28 September 2018 / Published: 4 October 2018
(This article belongs to the Special Issue Non-Coding RNA, Fibrogenesis, and Fibrotic Disease)
Transforming growth factor-β (TGF-β) is a crucial mediator in tissue fibrosis that promotes accumulation of extracellular matrix (ECM), myofibroblasts to epithelial–mesenchymal transition (EMT), endothelial-mesenchymal transition (EndoMT), and apoptosis via canonical and noncanonical signaling pathways. In the past decades, a number of microRNAs have been reported to participate in TGF-β-mediated tissue scarring; however, the roles of long noncoding RNAs (lncRNAs) in fibrogenesis remain largely unknown. Recently, emerging evidence has shown that lncRNAs are involved in the development of different diseases, including cancer, autoimmune diseases, cardiovascular diseases, and fibrotic diseases. In this review, we summarize the current updates of lncRNAs in TGF-β1-driven tissue fibrosis and discuss their therapeutic potential for the treatment of chronic fibrotic diseases. View Full-Text
Keywords: long noncoding RNA; fibrosis; transforming growth factor-β long noncoding RNA; fibrosis; transforming growth factor-β
Show Figures

Figure 1

MDPI and ACS Style

Tang, P.M.-K.; Zhang, Y.-Y.; Lan, H.-Y. LncRNAs in TGF-β-Driven Tissue Fibrosis. Non-Coding RNA 2018, 4, 26.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop